BIOTHEUS

biotheus-logo

Biotheus is an up-and-coming biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus is committed to research and development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

#SimilarOrganizations #People #Financial #Website #More

BIOTHEUS

Industry:
Biotechnology Health Care

Founded:
2018-01-01

Address:
Zhuhai, Guangdong, China

Country:
China

Website Url:
http://www.biotheus.com

Total Employee:
51+

Status:
Active

Total Funding:
119.53 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Mobile Non Scaleable Content Euro Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

apeiron-biologics-logo

Apeiron Biologics

Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

genequantum-healthcare-logo

GeneQuantum Healthcare

GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.

gossamer-bio-logo

Gossamer Bio

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

liscure-biosciences-logo

LISCure Biosciences

LISCure Biosciences is a biotech company that researches and develops bacteria-mediated immunotherapy.

lynk-pharmaceuticals-logo

LYNK Pharmaceuticals

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.

mabspace-biosciences-logo

MabSpace Biosciences

MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

rnaimmune-logo

RNAimmune

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

salubrisbio-logo

SalubrisBio

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

Current Employees Featured

andy-tsun_image

Andy Tsun
Andy Tsun VP of Discovery Biology & Co-Founder @ Biotheus
VP of Discovery Biology & Co-Founder
2018-08-01

xiaolin-liu_image

Xiaolin Liu
Xiaolin Liu CEO & Founder @ Biotheus
CEO & Founder
2018-04-01

joanne-sun_image

Joanne Sun
Joanne Sun SVP and Co-Founder @ Biotheus
SVP and Co-Founder
2018-05-01

Founder


andy-tsun_image

Andy Tsun

joanne-sun_image

Joanne Sun

xiaolin-liu_image

Xiaolin Liu

Investors List

huajin-financial-international-holdings_image

Huajin Financial International Holdings

Huajin Financial International Holdings investment in Series B - Biotheus

shiyu-capital_image

Shiyu Capital

Shiyu Capital investment in Series B - Biotheus

new-alliance-capital_image

New Alliance Capital

New Alliance Capital investment in Series B - Biotheus

citic-pe_image

CPE

CPE investment in Series B - Biotheus

idg-capital-partners_image

IDG Capital

IDG Capital investment in Series B - Biotheus

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Series B - Biotheus

general-atlantic_image

General Atlantic

General Atlantic investment in Series B - Biotheus

kunlun-capital_image

Kunlun Capital

Kunlun Capital investment in Series B - Biotheus

hlc-equity_image

HLC Equity

HLC Equity investment in Series B - Biotheus

cowin-capital_image

Cowin Capital

Cowin Capital investment in Series B - Biotheus

Official Site Inspections

http://www.biotheus.com

  • Host name: 120.133.60.61
  • IP address: 120.133.60.61
  • Location: China
  • Latitude: 34.7725
  • Longitude: 113.7266
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Biotheus"

Biotheus - Crunchbase Company Profile & Funding

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»

Biotheus

BiotheusIn the future, Biotheus will quickly become the first echelon of domestic biopharmaceutical companies with its high-value product chain, strong innovation capabilities, โ€ฆSee details»

Biotheus Company Profile - Office Locations, Competitors ... - Craft

Biotheus has 5 employees across 3 locations and $114.53 m in total funding,. See insights on Biotheus including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

BioNTech Completes Acquisition of Biotheus | BioNTech

Feb 3, 2025 Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the โ€ฆSee details»

Biotheus Announces Strategic Research Collaboration and โ€ฆ

Jul 20, 2023 Biotheus Inc. is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies and cell therapies to address the unmet medical โ€ฆSee details»

Biotheus Inc. (CN) - life-sciences-asia.com

Biotheus Inc. is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies and cell therapies to address the unmet medical needs of patients โ€ฆSee details»

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with โ€ฆ

Oct 2, 2024 Under this agreement, Biotheus will receive a specialized antibody asset from Talem Therapeutics, a subsidiary of ImmunoPrecise Antibodies. Biotheus plans to use this โ€ฆSee details»

BioNTech Completes Acquisition of Biotheus - drug-dev.com

Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the Companyโ€™s โ€ฆSee details»

BioNTech Completes Acquisition of Biotheus to Enhance Oncology โ€ฆ

Feb 3, 2025 Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the โ€ฆSee details»

BioNTech to Acquire Biotheus to Boost Oncology Strategy

Nov 13, 2024 About Biotheus Biotheus is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies to address the unmet medical needs โ€ฆSee details»

Biotheus

Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech ZHUHAI, China, July 19, 2023 /PRNewswire/ -- Biotheus Inc. ("Biotheus"), a clinical โ€ฆSee details»

Biotheus - Funding, Financials, Valuation & Investors

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»

BioNTech Completes Acquisition of Biotheus - pharmiweb.jobs

Feb 4, 2025 BioNTech SE (Nasdaq: BNTX, โ€œBioNTechโ€ or โ€œthe Companyโ€) announced today the completion of the acquisition of Biotheus (โ€œBiotheusโ€), a clinical-stage biotechnology company โ€ฆSee details»

Biotheus - Contacts, Employees, Board Members, Advisors & Alumni

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»

BioNTech to Acquire Biotheus to Boost Oncology Strategy

Nov 13, 2024 Biotheus is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies to address the unmet medical needs of patients โ€ฆSee details»

BioNTech buys Biotheus and its Keytruda rival for $950m

Nov 13, 2024 BioNTech snaps up Chinese bispecific antibody partner Biotheus in $950m deal, claiming full control of Keytruda rival.See details»

BioNTech Completes Acquisition Of Biotheus; Boosts Oncology โ€ฆ

Feb 3, 2025 Biotheus will now operate as an indirect Chinese subsidiary of BioNTech, expanding BioNTech's global network with a local research and development hub and an โ€ฆSee details»

BioNTech Acquires Biotheus To Boost Oncology Strategy

On February 3, 2025, BioNTech SE (โ€œBioNTechโ€) confirmed the completion of its acquisition of biotechnology company Biotheus for an upfront payment of $800 million and up to $150 million โ€ฆSee details»

Biotheus - Updates, News, Events, Signals & Triggers

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»

Biotheus - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Apr 27, 2025 Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.See details»

linkstock.net © 2022. All rights reserved